Hormel Foods has voluntarily recalled 153 cases of a batch of its Skippy peanut butter due to the likelihood that certain jars contain small metal shavings, as discovered through a magnet check during routine cleaning.
The recall covered about 1,871 pounds of Skippy Reduced Fat Creamy Peanut Butter Spread – the 16.3-ounce jars with a “Best If Used By” date of DEC1416LR1. The package UPC code is 37600-10500, with code date found on top of product lid.
Stocks affected by the recall were specifically sent to distribution centers for Publix, Target, and Walmart situated in Alabama, Arkansas, Delaware, Georgia, South Carolina, and Virginia.
The recall statement posted by the U.S. Food and Drug Administration (FDA) on its website warned that objects in food products that are longer than seven millimeters may lead to severe choking with obstruction of airways, gastrointestinal peroration, and other forms of injury.
According to the statemtent, no reports of any consumer injury or complaint yet had been received. No other varieties, sizes, or packaging types of the peanut butter or other peanut spreads were covered by the recall.
Customers who purchased affected items may ask for an exchange by returning it to the store where they purchased. They may call Hormel Foods at 1-866-475-4779 from Monday to Friday, 8 a.m. to 4 p.m. Central Time.
Within about one month, this is the second incident of a product recall due to metal shards. Mississippi-based Sanderson Farms recalled some 554,090 pounds of poultry products in late September because of worrisome metal contamination.
Based on the recall statement, the company determined that the metal contamination took place due to “a malfunction with an ice-making machine used during production,” with the issue discovered after processing facility complained about metal traces in the product.
The recall covered specific case codes of boneless skinless chicken breast fillets, tenderloins, breast butterflies, and breast frames made from Sept. 17 to 18.
Food and pharmaceutical recalls that have been reported to the FDA involved issues such as undeclared soy, Clostridium bacterium contamination, addition of an unapproved new drug, undeclared allergens, and inaccurate drug dosage delivery.
Photo: Mike Mozart | Flickr
